The following products have been found matching your search "incident": 453
Or did you mean: including | FIND ME THIS PAPER Ball et al. (2022): This study highlights the increased incidence of hypoglycemic episodes in diabetic patients, particularly those with Type 1 diabetes, due to disruptions in glucose homeostasis during fasting periods. The study unders | indirect | instrument | independent | Instrument Warranty | PLOIDY-3-AB - Instrument | inside
No results were found for the filter!
APC-Cy7
CyFlow™ CD38 APC-Cy7
Antigen: | CD38 |
Clone: | HIT2 |
Regulatory Status: | ASR |
Target Species: | Human |
$515.00 USD
PE-DyLight™ 594
CyFlow™ CD56 PE-DyLight™ 594
Antigen: | CD56 |
Clone: | LT56 |
Regulatory Status: | ASR |
Target Species: | Human |
$595.00 USD
PerCP-Cy5.5
CyFlow™ CD79a PerCP-Cy5.5
Antigen: | CD79a |
Clone: | HM57 |
Regulatory Status: | ASR |
Target Species: | Human |
$595.00 USD
APC-Cy7
CyFlow™ CD117 APC-Cy7
Antigen: | CD117 |
Clone: | 104D2 |
Regulatory Status: | ASR |
Target Species: | Human |
$515.00 USD
FITC
CyFlow™ CD123 FITC
Antigen: | CD123 |
Clone: | 6H6 |
Regulatory Status: | ASR |
Target Species: | Human |
$410.00 USD
Alexa Fluor™ 700
CyFlow™ HLA-DR Alexa Fluor™ 700
Antigen: | HLA-DR |
Clone: | L243 |
Regulatory Status: | ASR |
Target Species: | Human |
$495.00 USD
Pacific Blue™
CyFlow™ CD2 Pacific Blue™
Antigen: | CD2 |
Clone: | LT2 |
Regulatory Status: | ASR |
Target Species: | Human |
$525.00 USD
PE-Cy7
CyFlow™ CD8 PE-Cy7
Antigen: | CD8 |
Clone: | MEM-31 |
Regulatory Status: | ASR |
Target Species: | Human |
$495.00 USD
PE-DyLight™ 594
CyFlow™ CD13 PE-DyLight™ 594
Antigen: | CD13 |
Clone: | WM15 |
Regulatory Status: | ASR |
Target Species: | Human |
$595.00 USD
PE-DyLight™ 594
CyFlow™ CD14 PE-DyLight™ 594
Antigen: | CD14 |
Clone: | MEM-15 |
Regulatory Status: | ASR |
Target Species: | Human |
$595.00 USD
APC
PE
CyFlow™ CD157 PE
Antigen: | CD157 |
Clone: | SY11B5 |
Regulatory Status: | ASR |
Target Species: | Human |
$445.00 USD